Trial Profile
A Single-arm Study to Evaluate the Efficacy of Intercalated Combination of Chemotherapy and Gefitinib as First-line Treatment for Patients With Non-Small-Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Aug 2016 Status changed from not yet recruiting to recruiting.
- 21 Mar 2014 New trial record